Activated G␣13 stimulated the RhoGEF activity of p115 through interaction with the N-terminal RGS domain. However, G␣12 could not activate Rho through p115, although it interacted with the RGS domain of p115. The biochemical mechanism from G␣12 to Rho activation remained unknown. In this study, we analyzed the interaction of leukemia-associated RhoGEF (LARG), which also contains RGS domain, with G␣12 and G␣13. RGS domain of LARG demonstrated G␣12-and G␣13-specific GAP activity. LARG synergistically stimulated SRF activation by G␣12 and G␣13 in HeLa cells, and the SRF activation by G␣12-LARG was further stimulated by coexpression of Tec tyrosine kinase. It was also found that LARG is phosphorylated on tyrosine by Tec. In reconstitution assays, the RhoGEF activity of nonphosphorylated LARG was stimulated by G␣13 but not G␣12. However, when LARG was phosphorylated by Tec, G␣12 effectively stimulated the RhoGEF activity of LARG. These results demonstrate the biochemical mechanism of Rho activation through G␣12 and that the regulation of RhoGEFs by heterotrimeric G proteins G12͞13 is further modulated by tyrosine phosphorylation.
M
embers of the Rho family GTPases (Rho, Rac, and Cdc42) regulate a variety of cellular activities such as cell-cycle progression, chemotaxis, or axonal guidance by controlling actin cytoskeletal rearrangements or gene expression (1) . Activation of Rho family GTPases is catalyzed by their guanine nucleotide exchange factors (GEFs). These GEFs share a Dbl homology domain and an adjacent pleckstrin homology domain (2) . The Dbl homology domain is responsible for the capacity to stimulate GDP-GTP exchange of Rho family GTPases. Except for this common Dbl homology-pleckstrin homology structure, these GEFs contain various protein motifs that are implicated in signal transduction. However, the biochemical mechanism of regulation of these GEFs by upstream signals has been poorly understood.
Heterotrimeric G proteins G12 and G13 have been shown to mediate signals from G protein-coupled receptors to Rho GTPase activation (3) (4) (5) . Recently, we identified p115RhoGEF, one of GEFs for Rho, as a direct link between heterotrimeric G13 and Rho (6, 7) . Activated G␣13 stimulated the RhoGEF activity of p115 through the interaction with the N-terminal RGS (regulator of G protein signaling) domain. However, G␣12 did not activate Rho through p115 in reconstitution assays. Although the overexpression of a constitutively active mutant of G␣12 has demonstrated several evidences supporting Rho activation in cells (5, 8) , the biochemical mechanism from G␣12 to Rho activation has not been understood.
Recently, several reports indicated the involvement of tyrosine phosphorylation in the regulation of GEF activity for Rho family GTPases. Tyrosine phosphorylation of Vav or Vav-2 was required for their GEF activity (9, 10) . GEF activity of Dbl for Rho and Cdc42 was enhanced by tyrosine phosphorylation by ACK-1 (11) . It was also demonstrated that several tyrosine kinase inhibitors blocked G␣12-or G␣13-mediated Rho activation in cells (12, 13) . In addition, the involvement of Tec family tyrosine kinases in G12͞13-mediated signaling pathway was demonstrated in cell-based assays as well as in in vitro experiments (14, 15) . Tec kinases form a family of nonreceptor tyrosine kinases that share pleckstrin homology and Tec homology (TH) domains at the N-terminal region (16) . These kinases are activated by various stimuli, including ligands for G protein-coupled receptors (17) . However, their regulatory functions in cells remain unclear.
In this study, we investigated the possibility that RhoGEF other than p115 might be responsible for mediating signals from G␣12 to Rho. We found that leukemia-associated RhoGEF (LARG) could transduce G␣12-mediated Rho activation when it was phosphorylated by Tec tyrosine kinase.
Methods
Construction of Plasmids. KIAA0382 was originally isolated as a partial cDNA lacking N-terminal PDZ and RGS domains (18) . Full-length cDNA was obtained by 5Ј-RACE using KIAA0382 as a template and human brain cDNA library (CLONTECH). The full-length cDNA had an identical amino acid sequence with LARG. LARG (1-1543), ⌬PDZ-LARG (307-1543), ⌬N-LARG (617-1543), PDZ-RhoGEF, p115RhoGEF, Tec (1-629), and kinase domain-deleted Tec (Tec-KD) (1-358) were subcloned into pcDNA-myc vector with N-terminal myc-tag. cDNAs for Tec lacking TH domain (⌬TH-Tec) and the constitutively active form of Tec (mHTec), which has N-terminal myristoylation signal, were subcloned into pSR␣ mammalian expression vector (17, 19) . cDNAs encoding the constitutively active G␣12 (G␣12Q229L) and G␣13 (G␣13Q226L) were subcloned into pCMV5 vector. SRE.L-luciferase reporter plasmid and an expression construct for GST-fused RhoA binding domain of Rhotekin (GST-RBD) were kindly provided by P. C. Sternweis (University of Texas Southwestern Medical Center) and G. Bokoch (The Scripps Research Institute, La Jolla, CA), respectively. SRE-Luciferase Assay. HeLa cells (6 ϫ 10 4 cells per well) were plated onto 24-well plates 1 day before transfection. Cells were cotransfected with SRE.L-luciferase reporter plasmid (0.1 g), pCMV␤gal (0.1 g), and the indicated cDNAs. The cells were cultured in the presence of 10% FCS for 5 h and then serum-starved for 24 h. Luciferase activities in cell extracts were measured according to the manufacturer's instruction (Promega). Total amounts of transfected DNA were kept constant among wells by supplementing the empty vector DNA. ␤-Galactosidase activities of cell lysates were used to normalize for the transfection efficiency.
six-histidine tag at the N terminus (Life Technologies, Grand Island, NY), and their recombinant baculoviruses were generated. Sf9 cells (1.8 ϫ 10 6 cells per ml) were infected with corresponding recombinant baculovirus and harvested after 48 h. Cells were resuspended in lysis buffer (20 mM Hepes, pH 8.0͞50 mM NaCl͞0.1 mM EDTA͞10 mM 2-mercaptoethanol and protease inhibitors) and lysed by nitrogen cavitation. The lysates were centrifuged at 100,000 ϫ g and 4°C for 30 min. The supernatants were loaded onto Ni-NTA column equilibrated with buffer A (20 mM Hepes, pH 8.0͞100 mM NaCl͞10 mM 2-mercaptoethanol). The column was washed with 10 column volumes of buffer B (buffer A containing 400 mM NaCl and 10 mM imidazole). Recombinant LARG was eluted by 10 column volumes of buffer C (buffer A containing 150 mM imidazole). The elution fractions were concentrated and the buffer was exchanged with buffer D (buffer A containing 10% glycerol).
p115RhoGEF and RhoA were prepared as described (6, 7). G␣12 and G␣13 were purified using the Sf9-baculovirus expression system as described (20) , with the following modification for G␣13 purification. Instead of 1% octylglucoside, 0.2% n-dodecyl-␤-D-maltoside and 10% glycerol were included in the elution buffer of G␣13 from Ni-NTA column.
RhoGEF Assay. RhoA loaded with [ 3 H]GDP (100 nM, 2,000 cpm͞pmol) was incubated with the indicated proteins at 20°C in GEF assay buffer (50 mM Tris⅐HCl, pH 7.5͞50 mM NaCl͞1 mM EDTA͞1 mM DTT͞10 mM MgCl 2 ͞5 M GTP␥S͞0.1% C 12 E 10 ) in a final volume of 20 l. G protein ␣ subunits were preincubated in the presence of AMF (30 M AlCl 3 ͞5 mM MgCl 2 ͞10 mM NaF) and added to the GEF reaction mixture. The reactions were stopped by the addition of 2 ml of washing buffer (20 mM Tris⅐HCl, pH 7.5͞40 mM MgSO 4 ͞100 mM NaCl), followed by filtration through BA-85 filters (Schleicher & Schuell). The amount of [ 3 H]GDP that remained on the filter was determined by a liquid scintillation counter.
To prepare Tec for GEF assays, COS1 cells were transfected with myc-tagged Tec. After 24 h, cells were lysed in the lysis buffer (50 mM Tris⅐HCl͞150 mM NaCl͞1% Nonidet P-40͞1 mM EDTA͞1 mM DTT͞10 mM ␤-glycerophosphate͞10 mM Na 3 VO 4 and protease inhibitors) and centrifuged at 200,000 ϫ g for 20 min. The supernatants were incubated with anti-myc antibody 9E10 (Covance). Tec was immunoprecipitated using protein G-agarose (Santa Cruz Biotechnology) and resuspended in GEF buffer.
To prepare phosphorylated LARG, Tec immunoprecipitated from COS1 cells was mixed with LARG and incubated at 20°C for 40 min in GEF buffer with 100 M ATP. Then, [ 3 H]GDPloaded RhoA (100 nM) and AlF 4 Ϫ -activated G␣ were added to the GEF reaction mixture. The mixture was further incubated at 20°C for the indicated time. The dissociation of GDP from RhoA was measured as described above.
To measure RhoGEF activity in cells, endogenous GTPbound RhoA in cell lysate were detected by their association with GST-RBD as described by Ren and Schwartz (21) . Phosphorylation Assay. Tec or Tec-KD was overexpressed in COS1 cells, prepared as described above, and was resuspended in the kinase buffer (20 mM Tris⅐HCl, pH 7.4͞50 mM NaCl͞10 mM MgCl 2 ͞2 mM MnSO 4 ͞100 M ATP). RhoGEF with or without G␣12͞13 was incubated with Tec in the kinase buffer at 30°C for 20 min. The reactions were terminated by adding SDS͞PAGE sample buffer, and the samples were separated by SDS͞PAGE, followed by immunoblotting using anti-Tec antibody (17) or antiphosphotyrosine antibody PY20 (Zymed).
For the assessment of phosphorylation in vivo, HEK293 cells were cotransfected with myc-tagged ⌬PDZ-LARG, ⌬N-LARG, or p115 and the constitutively active Tec (mHTec). After 24 h, cells were lysed and LARG was immunoprecipitated by anti-myc antibody. The immunoprecipitates were subjected to SDS͞ PAGE and analyzed by immunoblotting with PY20 antibody.
Miscellaneous Procedures. Immunoblotting was performed using the chemiluminescent detection system (Pierce). GTPase assays for G␣ subunits were performed as described (6) .
Results
In addition to p115RhoGEF, two mammalian RhoGEFs, PDZRhoGEF (KIAA0380) and LARG, were identified to have an RGS domain in their N-terminal region (refs. 18 and 22; Fig. 1A) . It was shown that PDZ-RhoGEF and LARG interacted with constitutively active mutants of G␣12 and G␣13 through their RGS domains (23, 24) . However, the biochemical mechanism to regulate the RhoGEF activity of PDZ-RhoGEF or LARG by G␣12͞13 has not been elucidated. To examine whether PDZRhoGEF or LARG can mediate the signal from G␣12 or G␣13 to Rho activation, we first performed SRE-luciferase reporter assays. It has already been shown that G␣12͞13-mediated Rho activation could be monitored in cells by SRF activation (25) . As shown in Fig. 1B , overexpression of a constitutively active mutant of G␣12 (G␣12Q229L) or G␣13 (G␣13Q226L) modestly stimulated SRF activity, whereas coexpression of these mutants with LARG or PDZ-RhoGEF synergistically potentiated SRF activation. In particular, SRF activation by PDZ-RhoGEF or LARG and G␣12 was almost similar to the level with these RhoGEFs and G␣13. We could not detect similar synergistic SRF activation by using p115RhoGEF in the assay. The results suggest that PDZ-RhoGEF or LARG may transduce the signal from both G␣12 and G␣13 to Rho activation. In this study, we focused on the function of LARG in G12͞13-mediated signaling.
We examined the biochemical interaction of G␣12͞13 with LARG in vitro by using purified components. G␣ subunits and RhoGEFs were expressed in and purified from Sf9 cells (Fig.  2A) . As shown in Fig. 2B , the constructs of LARG that contain the RGS domain demonstrated GAP activity for G␣12 or G␣13 similar to p115RhoGEF. However, a construct of LARG lacking the RGS domain did not show any GAP activity. The RGS domain of LARG did not have GAP activity for G␣s, G␣i, G␣o, and G␣q (data not shown). Thus, the RGS domain of LARG serves as a specific GAP for G␣12 or G␣13 similar to that of p115RhoGEF.
We also examined the regulation of RhoGEF activity of LARG by G␣12͞13. In the case of p115RhoGEF, G␣13, but not G␣12, stimulated its RhoGEF activity (7) . As shown in Fig. 2C , AlF 4 Ϫ -activated G␣13 stimulated the RhoGEF activity of LARG. However, AlF 4 Ϫ -activated G␣12 did not demonstrate RhoGEF activation. Thus, although SRF assays suggested that G␣12-LARG mediated Rho activation in HeLa cells, we could not reconstitute that pathway in vitro. The results suggest that additional factors or some modification on G␣12 or LARG will be necessary for activation of Rho through the G␣12-LARG pathway.
Because the involvement of Tec kinase has been reported in the G␣12-mediated pathway, we tested the possibility that Tec tyrosine kinase might be involved in Rho activation through G␣12͞13-LARG. As shown in Fig. 3A , coexpression of Tec kinase in HeLa cells potently stimulated both G␣12-and G␣13-LARG-mediated SRF activation. However, we did not observe a similar effect of Tec when G␣12͞13 or LARG was expressed alone. Coexpression of Tec did not stimulate SRF activation mediated by G␣12͞13-p115RhoGEF (data not shown). In addition, a kinase-deficient mutant of Tec (Tec-KD) failed to stimulate the G␣12͞13-LARG-mediated SRF activation. GTPbound Rho pull-down assay also demonstrated that Rho activation by G␣12-LARG in HeLa cells was further stimulated by Tec (Fig. 3B) . These results suggest that Tec tyrosine kinase regulates G␣12͞13-LARG-mediated Rho activation by phosphorylating some component of the pathway.
The interaction of G␣12 with Btk, another member of the Tec family, through its pleckstrin homology-TH domain was recently demonstrated (15) . As shown in Fig. 3C , we could also observe the interaction between constitutively active G␣12QL and Tec by coimmunoprecipitation. Furthermore, a Tec construct lacking TH domain did not show the stimulatory effect on G␣12-LARGmediated SRF activation, indicating that the TH domain of Tec is required for its effect on the G␣12͞13-LARG pathway (Fig. 3D) .
We next examined whether Tec can directly phosphorylate G␣12͞13 or LARG. Myc-tagged Tec was overexpressed in COS1 cells, immunoprecipitated by anti-myc antibody, and used for in vitro phosphorylation assays. As shown in Fig. 4A , ⌬PDZ-LARG was phosphorylated on tyrosine by Tec. However, p115RhoGEF, G␣12, or G␣13 did not serve as a substrate for Tec. Moreover, the activated G␣12 or G␣13 did not affect the phosphorylation of LARG by Tec. We also examined tyrosine phosphorylation of LARG in cells. A Tec construct with an N-terminal myristoylation signal (mHTec) was targeted to the plasma membrane and exhibited constitutive activity (19) . As shown in Fig. 4B , ⌬PDZ-LARG, but not p115, was tyrosine phosphorylated in HEK293 cells when coexpressed with mHTec. However, we could not detect tyrosine phosphorylation of ⌬N-LARG under the same condition. These results suggest that Tec phosphorylates LARG in vivo as well as in vitro. Furthermore, the phosphorylation site on LARG is likely in the region including its RGS domain (amino acid residues 307-617 of LARG). Finally, we examined the effect of phosphorylation of LARG on its RhoGEF activity (Fig. 4 C and D) . LARG was first phosphorylated by preincubation with Tec, and then RhoGEF assays were started by adding RhoA and G␣ subunits. The preincubation with Tec did not affect the basal RhoGEF activity of LARG. However, G␣12 stimulated the RhoGEF activity of LARG in a phosphorylation-dependent manner. This stimulation was almost similar to the level by G␣13 without Tec. The stimulatory effect by G␣12 was also dependent on the presence of ATP during preincubation (data not shown), confirming that the phosphorylation of LARG is required for G␣12 to activate Rho. These results indicate that G␣12 can activate Rho through phosphorylated LARG. Tyrosine phosphorylation of LARG also modestly stimulated RhoGEF activity mediated by G␣13 (Fig. 4D) .
Discussion
The results of this study demonstrated the biochemical mechanism of Rho activation through G␣12. Although G␣12 and G␣13 are similar in amino acid sequences and biochemical properties and both are involved in Rho activation, several studies indicated the functional differences between these two G␣ subunits. The most striking difference was demonstrated in G␣13 gene knockout mice, which showed embryonic lethality due to the defect of vascular system formation (26). G␣12 could not rescue the function of G␣13 in these mice. In reconstitution experiments, G␣13 stimulated the GEF activity of p115RhoGEF. However, G␣12 could not stimulate the GEF activity of p115 and competitively inhibited the stimulatory effect of G␣13 (7) . In this report, we demonstrated that the tyrosine phosphorylation of LARG is required for G␣12 to activate Rho. Although tyrosine phosphorylation of LARG could further stimulate the effect of G␣13, it was not required for Rho activation by G␣13. These differences in the regulatory mechanisms of G␣12-and G␣13-mediated pathways may be responsible for the different cellular effects induced by G␣12 or G␣13.
Because the TH domain was required for Tec to stimulate G␣12-LARG-mediated SRF activation, this domain may be involved in the interaction with G␣12 similar to the case of Btk. However, we could not detect the activation of Tec kinase by G␣12 in vitro (data not shown). The exact mechanism of G␣12 to regulate Tec kinase is currently unclear. However, it is interesting to note that thrombin, which can activate the G␣12͞13 pathway, has also been reported to activate Tec in platelets (17) . It is possible that activated G␣12 may recruit Tec 
